SE9500270D0 - Medicines for deficiency - Google Patents

Medicines for deficiency

Info

Publication number
SE9500270D0
SE9500270D0 SE9500270A SE9500270A SE9500270D0 SE 9500270 D0 SE9500270 D0 SE 9500270D0 SE 9500270 A SE9500270 A SE 9500270A SE 9500270 A SE9500270 A SE 9500270A SE 9500270 D0 SE9500270 D0 SE 9500270D0
Authority
SE
Sweden
Prior art keywords
substance
proline
deficiency
intended
aforementioned
Prior art date
Application number
SE9500270A
Other languages
Swedish (sv)
Other versions
SE9500270L (en
Inventor
Anders Jonsson
Original Assignee
A K J Medi Konsult Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A K J Medi Konsult Ab filed Critical A K J Medi Konsult Ab
Priority to SE9500270A priority Critical patent/SE9500270L/en
Publication of SE9500270D0 publication Critical patent/SE9500270D0/en
Priority to PCT/SE1996/000305 priority patent/WO1996027371A1/en
Priority to AU49614/96A priority patent/AU4961496A/en
Publication of SE9500270L publication Critical patent/SE9500270L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Abstract

The invention relates to a substance intended to be administered in a deficiency condition resulting in collagen insufficiency in the mesodermal, ectodermal and endodermal tissue, or for the purpose of preventing the aforementioned deficiency condition, and intended to undergo further development as a drug to be used for appropriate indications. The amino acid Lysine, preferably 1-Lysine, is present in the aforementioned substance, and the substance also contains Glycine, preferably 1-Glycine, and Proline, preferably 1-Proline, as a mixture.
SE9500270A 1995-01-25 1995-01-25 Medicines for deficiency conditions SE9500270L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9500270A SE9500270L (en) 1995-01-25 1995-01-25 Medicines for deficiency conditions
PCT/SE1996/000305 WO1996027371A1 (en) 1995-01-25 1996-03-08 Product against deficiency
AU49614/96A AU4961496A (en) 1995-01-25 1996-03-08 Product against deficiency

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500270A SE9500270L (en) 1995-01-25 1995-01-25 Medicines for deficiency conditions

Publications (2)

Publication Number Publication Date
SE9500270D0 true SE9500270D0 (en) 1995-01-25
SE9500270L SE9500270L (en) 1996-09-09

Family

ID=20396965

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500270A SE9500270L (en) 1995-01-25 1995-01-25 Medicines for deficiency conditions

Country Status (3)

Country Link
AU (1) AU4961496A (en)
SE (1) SE9500270L (en)
WO (1) WO1996027371A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4383196A (en) * 1996-01-17 1997-08-11 Friedrich Kisters Amino acid preparation for stimulating hair growth
IT1304191B1 (en) * 1998-12-18 2001-03-08 Solartium Establishment PHARMACEUTICAL COMPOSITION BASED ON PROLIN, GLYCINE AND LYSINE USEFUL IN DENTAL THERAPY BOTH INJECTABLE AND INJECTABLE FORM
DE10106852A1 (en) 2001-02-14 2002-09-05 T Luger Anti-inflammatory compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900701250A (en) * 1988-06-16 1990-12-01 죠셉 애슬리 Cosmetic and skin treatment composition
US5198465A (en) * 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
DE4243363A1 (en) * 1992-12-21 1994-06-23 Ulrich Dr Med Kuebler Treatment of dry skin
DE4243362A1 (en) * 1992-12-21 1994-06-23 Ulrich Dr Med Kuebler Agent for treating skin dryness and neuro:endocrine and immune system

Also Published As

Publication number Publication date
AU4961496A (en) 1996-09-23
WO1996027371A1 (en) 1996-09-12
SE9500270L (en) 1996-09-09

Similar Documents

Publication Publication Date Title
ATE249422T1 (en) COMPOUNDS AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE SUBSTANCES
ATE257386T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES
EA199700239A1 (en) THROMBIN INHIBITORS BASED ON AMINO ACID SEQUENCE OF HIRUDIN
IS4083A (en) Composition of pharmaceutical substances, method of manufacture thereof, and use as pharmaceuticals
DE68917512D1 (en) Cosmetic preparation.
AU694229B2 (en) A pharmaceutical preparation comprising glucagon
BR9606604A (en) Compound and method for the manufacture of a medicine or to improve the transport of a drug or other asset to cross the lipid membranes in the body or ensure action
EA199800946A1 (en) CONCENTRATED ANTIBODY PREPARATION
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
ATE183514T1 (en) HUMAN PROTEIN P53 PEPTIDES FOR USE IN HUMAN CYTOTOXIC T CELL RESPONSE-INDUCING COMPOSITIONS AND HUMAN P53 PROTEIN SPECIFIC T LYMPHOCYTES
ATE262348T1 (en) AGENT FOR ADMINISTRATION OF ANTIGENS
TR200000369T2 (en) Production of combined pharmaceutical preparations for use in the treatment of rheumatic diseases.
PL319259A1 (en) Scopolamine containing plaster
DE59609508D1 (en) CONJUGATE CONTAINING DTPA AND ALBUMIN FOR THE INDIVIDUAL DOSAGE OF MEDICINAL PRODUCTS
SE9500270D0 (en) Medicines for deficiency
DE69841573D1 (en) METHOD FOR INCREASING MAGNESIUM ABSORPTION AND PREVENTING ARTHEROSCLEROSIS
ES2085199B1 (en) A PROCEDURE FOR THE PREPARATION OF A DEPOT FORMULATION.
ATE346863T1 (en) USE OF EIF4E BINDING REAGENTS IN THERAPY
ATE88350T1 (en) DRUG.
DK0927031T3 (en) Pharmaceutical composition containing nimesulide for oral administration
TR199900748A2 (en) Using combination of osteinductive protein and dorsalizing factor.
EA200100477A1 (en) PHARMACEUTICAL COMPOSITION THP AND ENALAPRIL
DE3879489T2 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING ADRENOLEUKODYSTROPHY.
RU94036666A (en) Biostimulating agent
RU96102110A (en) METHOD FOR PREVENTION AND TREATMENT OF CORNERAL ULCER

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9500270-5